Targeted therapies are a type of medicine used to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted ...
"In this study, we demonstrated that pathogenic variants of ERBB2 were related to the efficacy of HER2-targeted therapy and identified novel splice variants associated with drug resistance. Acquired ...
Region-specific biomarkers FGFR4, FLT1, and WNT5A are linked to tumor behavior and therapeutic response in CRC. Comprehensive genomic profiling (CGP) aids in precision medicine by identifying genetic ...
Adopting evidence-based, unified scoring criteria specifically validated for colorectal cancer could help ensure that the right patients receive the right targeted treatment at the right time.
SELLAS Life Sciences Group, Inc. announced promising preclinical results for SLS009 (tambiciclib) in treating ASXL1 mutated colorectal cancer, highlighted at the 2025 ASCO Annual Meeting. In studies, ...
11don MSN
BRAF gene mutation leads to different therapeutic responses in melanoma and colorectal cancer
A review article led by researchers from the B·ARGO group at the Germans Trias i Pujol Research Institute (IGTP) and from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback